Oncolytics Biotech (Canada)

Oncolytics Biotech (Canada)

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Oncolytics Biotech (Canada), Canada, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

48%


Total
Publications

222


Total Open
Publications

106


Total
Citations

6.4K


Open Access
Percentage

48%


Total
Publications

222


Total Open
Publications

106


Total
Citations

6.4K

Wikipedia

Website

download

Breakdown

16% 26% 6% 52%

Publisher Open

16%

Both

26%

Other Platform Open

6%

Closed

52%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02468101214161820Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

27%OA Journal

OA Journal 27%

25

Hybrid 35%

33

No Guarantees 38%

35

Other Platform Open

Domain 86%

61

Institution 27%

19

Public 14%

10

Preprint 8%

6

Other Internet 7%

5

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
61
Europe PMC
Domain
42
DOI
Other Internet
20
Figshare
Public
12
whiterose.ac.uk OAI-PMH Repository
Institution
11
Research Square
Preprint
8
Semantic Scholar
Public
5
University of Surrey - Surrey Open Research repository
Institution
4
University College London - UCL Discovery
Institution
4
University of Leeds, The University of Sheffield, University of York - White Rose Research Online
Institution
3
1 / 2

Data updated 7 October 2024

Share

Share

Share